Relationship between a tumour marker - serum beta human chorionic gonadotropin [beta-hCG] - and age in female subjects

ABSTRACT

Cancer is a dreadful disease, which often proves fatal if not treated timely and properly. Early diagnosis can help in preventing cancer related deaths through successful therapy where tumour markers are present in the serum useful for diagnosis and monitoring tumour cases, through fluctuating levels in their serum. Beta human chorionic gonadotropin [beta-hCG] is a useful tumour marker. The present study was carried out to observe the association of beta-hCG level with age of female patients. Grouping on the basis of normal and raised beta-hCG levels demonstrated highly significant differences [p<0.001], while age did not vary significantly [p>0.05]. It was also observed that beta-hCG levels are higher in patients under 50 years while they are low in age group above 50 years